Ipramol Steri-Neb

Ipratropium bromide and salbutamol, the active ingredients in Ipramol Steri-Neb, are a combination bronchodilator presented as an inhalation solution for inhalation use. They treat bronchospasm associated with chronic obstructive pulmonary disease and asthma in adults.

GNH USA supplies Ipramol Steri-Neb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipramol Steri-Neb is a combination bronchodilator used to manage bronchospasm in obstructive airway diseases. - COPD: reduces bronchoconstriction and improves airflow during chronic obstructive pulmonary disease. - Asthma: provides rapid relief of bronchospasm in patients with asthma. - Acute bronchospasm episodes: delivers quick bronchodilation to alleviate sudden airway narrowing.

Ipramol Steri-Neb may cause a range of adverse reactions.

Common Side Effects: - Dry mouth: reduced salivary secretion. - Cough: irritation of the airway. - Throat irritation: mild soreness after inhalation. - Tremor: fine muscle shaking, especially of the hands. - Headache: mild to moderate intensity. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening airway narrowing. - Cardiac arrhythmia: irregular heart rhythm. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Angioedema: rapid swelling of face, lips, or tongue. - Hyperglycaemia: elevated blood glucose in susceptible individuals. - Hypokalaemia: low potassium levels, especially with high salbutamol exposure.

Before prescribing Ipramol Steri-Neb, clinicians should consider several safety factors. - Cardiac history: assess for arrhythmias or ischemic heart disease. - Thyroid disease: monitor patients with hyperthyroidism for tachycardia. - Glaucoma: use with caution in narrow‑angle glaucoma. - Over‑use: avoid excessive dosing to reduce risk of systemic effects. - Inhalation technique: ensure proper device use to maximise efficacy. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Ipramol Steri-Neb can interact with other medications that affect the cardiovascular or respiratory systems.

Major Interactions (Avoid): - Non‑selective β‑blockers: may blunt bronchodilator response and precipitate bronchospasm. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive episodes when combined with salbutamol.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate salbutamol‑induced hypokalaemia. - Theophylline: additive bronchodilator effect can increase side‑effect risk. - Tricyclic antidepressants: may enhance cardiac stimulation. - Other sympathomimetics: combined use can raise heart rate and blood pressure. - Anticholinergic agents: additive muscarinic blockade may increase dry‑mouth risk.